Access to health care
Health for all is the common vision of all human beings. With astrong focus on general idea of "pioneering and innovation and continuous progress", we have increased the R&D expenditure input constantly and been devoted to boosting drug R&D and innovation for multiple years. We established scientific research and innovation platform actively, improved IPRs protection system, promoted technological achievement transformation and contribute our power to people's health and well-being.
? In 2020, the total R&D investment is about RMB 619 million, and 26 R&D projects have been approved, including 6 innovative drug R&D projects
? In 2020, 11 production approval documents were obtained, 6 consistency evaluation product specifications were passed, 60 domestic patent authorizations were obtained
? In 2020, two provincial engineering technology centers – Guangzhou Engineering Technology Research Center for Andrology Medication and Guangdong Engineering Technology Center for Plant Beverage were established
? In 2020, National Laboratory Dog Resource Library of Guangzhou General Pharmaceutical Research Institute Co., Ltd. successfully developed the world's first gene edited human disease dog with Hemophilia A.
? In 2020, the number of varieties listed to health insurance directory was increased by 4; expired drug recovery project has been implemented for 17 consecutive years and a total of 6,000 drugstores in 200 cities in domestic China participated in the offline drug recovery.
? By the end of 2020, our Company has 5 national R&D institutions, 1 national enterprise technical center and 2 postdoctoral workstations, 16 provincial enterprise technical centers, 18 provincial engineering technicalcenters, 4 provincial key laboratories and 1 provincial engineer laboratory, 14municipal enterprise technical centers, 14 engineering technical R&Dcenters and 6 municipal key laboratories.
n Our Approach to Access to Health Care
We kept playing the main role of innovation, encouraged the R&Dof innovative drugs, accelerated the improvement of R&D platform scale constriction and provided new means and scheme for treatment of rare disease;boosted the development of primary medical care actively and improved medical service and medicine accessibility duly; closely followed the consumption trendchange, transformed product marketing mode flexibly and created brand scale effect; advocated the health idea to the public vigorously and created afavorable social atmosphere of healthy life.
n Our Stories